Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Perspectives on FIV vaccine development

J S Elyar1, M C Tellier, J M Soos

  • 1Department of Pathobiology, College of Veterinary Medicine, University of Florida, Gainesville 32610, USA.

Vaccine
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of copper sulfate application at an urban Brazilian reservoir: A geostatistical and ecotoxicological approach.

The Science of the total environment·2017
Same author

Pegylated feline granulocyte colony-stimulating factor increases neutrophil levels in cats.

Veterinary journal (London, England : 1997)·2014
Same author

Evolutionarily conserved T-cell epitopes on FIV for designing an HIV/AIDS vaccine.

Veterinary immunology and immunopathology·2011
Same author

Self-frequency doubling in Nd,Sc(2)O(3):LiNbO(3) at room temperature.

Optics letters·2009
Same author

Interferon-tau: prospects for clinical use in autoimmune disorders.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Same author

FIV-infected cats respond to short-term rHuG-CSF treatment which results in anti-G-CSF neutralizing antibody production that inactivates drug activity.

Veterinary immunology and immunopathology·2005

Feline immunodeficiency virus (FIV) causes a fatal disease in cats. Research into FIV vaccines, including conventional and novel approaches, offers insights for developing human immunodeficiency virus (HIV) vaccines.

Area of Science:

  • Veterinary Virology
  • Immunology
  • Vaccine Development

Background:

  • Feline immunodeficiency virus (FIV) causes feline immunodeficiency syndrome (FAIDS), a fatal disease in domestic cats.
  • Despite improved understanding of FIV immunopathogenesis, effective therapies and prophylaxis remain challenging due to viral adaptability.
  • FIV vaccine research parallels human immunodeficiency virus (HIV) vaccine efforts, with both successes and failures.

Purpose of the Study:

  • To review the current status of FIV vaccine research.
  • To discuss various vaccine types, including conventional, recombinant subunit, and vector-based vaccines.
  • To explore potential mechanisms of vaccine-induced protection against FIV.

Main Methods:

  • Literature review of FIV vaccine research.

Related Experiment Videos

  • Analysis of clinical trial data for different FIV vaccine candidates.
  • Examination of immunological data related to vaccine efficacy.

    • Main Results:

    • FIV vaccine development has encountered challenges similar to HIV vaccine research.
    • Various vaccine strategies, including subunit and vector-based approaches, have been explored.
    • Understanding FIV vaccine-induced protection mechanisms is crucial for future development.

    Conclusions:

    • Lessons from FIV vaccine research can inform strategies for HIV vaccine development.
    • Continued research into FIV vaccines is essential for feline health.
    • The adaptability of FIV highlights the complexities of retroviral vaccine design.